Michael Schemick
Director of Finance/CFO at Kaplan EduNeering, Inc.
Net worth: 9 M $ as of 2024-03-30
Profile
Currently, Michael Andrew Schemick occupies the position of Chief Financial Officer at Certara USA, Inc., Chief Financial Officer of Certara, Inc. and Chief Financial Officer of Kaplan EduNeering, Inc. Mr. Schemick is also on the board of Certara UK Ltd., LA-SER Europe Ltd., XenologiQ Ltd. and Certara UK Holdings Ltd. In the past he was Principal at Asbury Automotive Group, Inc., Vice President-Financial Planning & Analysis at Haights Cross Communications, Inc., Chief Financial Officer of Kaplan, Inc., Principal at Level 3 GC Ltd., Principal at Supresta LLC and Principal at Arthur Andersen LLP. Mr. Schemick received an MBA and an undergraduate degree from Rutgers State University of New Jersey.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
CERTARA, INC.
0.33% | 2023-03-30 | 522,895 ( 0.33% ) | 9 M $ | 2024-03-30 |
Michael Schemick active positions
Companies | Position | Start |
---|---|---|
Kaplan EduNeering, Inc.
Kaplan EduNeering, Inc. Miscellaneous Commercial ServicesCommercial Services Kaplan EduNeering, Inc. engages in the provision of online training services. The company was founded in 1980 and is headquartered in Princeton, NJ. | Director of Finance/CFO | 2010-04-27 |
Certara USA, Inc.
Certara USA, Inc. Miscellaneous Commercial ServicesCommercial Services Certara USA, Inc. provides drug development consultancy solutions. It offers benefits of modeling and simulation, label optimization, pediatric drug development, orphan drug development, clinical trial outcomes databases, and therapeutic areas. The company was founded in 2008 and is headquartered in Princeton, NJ. | Director of Finance/CFO | 2014-07-31 |
Certara UK Ltd.
Certara UK Ltd. BiotechnologyHealth Technology Certara UK Ltd. provides platforms for the modeling and simulation of pharmacokinetics and pharmacodynamics in virtual human populations and virtual laboratory animals. The company was founded by Geoffrey Thomas Tucker, Amin Rostami-Hodjegan, and John Evans on May 15, 2001 and is headquartered in London, the United Kingdom. | Director/Board Member | 2014-12-28 |
XenologiQ Ltd.
XenologiQ Ltd. Miscellaneous Commercial ServicesCommercial Services XenologiQ Ltd. provides consultancy services for the drug industry. It offers services in the areas of pharmacokinetic pharmacodynamics modelling, systems pharmacology and training. The firm projects include conference presentations; dose prediction for novel biological drugs and nerve growth factor pathways systems pharmacology. The company was founded in 2011 and is headquartered in London, United Kingdom. | Director/Board Member | - |
Certara UK Holdings Ltd.
Certara UK Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Certara, Inc., Certara UK Holdings Ltd. is a private company that develops drug therapies. The company is based in London, UK. Certara UK Holdings was founded in 2004. | Director/Board Member | 2014-11-30 |
LA-SER Europe Ltd.
LA-SER Europe Ltd. Pharmaceuticals: MajorHealth Technology LA-SER is a strongly science driven late-phase company with offices in 7 countries (UK, France, Germany, Spain, Italy, Canada and Morocco) encompassing a team of 150 specialists in late-phase clinical research. They cover a full range of late-phase services from observational studies, cohorts, registries, case-control studies, surveys, electronic health care database studies, pragmatic trials, they excel in risk/benefit management, effectiveness/relative effectiveness studies, and strategic consulting for drug value assessment. A truly unique feature is their in-depth understanding & knowledge of the process of drug value assessment, and of the methods, paradigms & modus operandi of regulatory decision-making bodies & agencies in several countries. Originally brought to the company by the founders of the company, this in-depth network knowledge is now shared by a large number of their senior staff. They can therefore provide remarkable insight into what evidence is required to grant market authorisation & reimbursement, for new drugs across different European countries & North America. | Director/Board Member | 2018-04-15 |
Certara Holdco, Inc.
Certara Holdco, Inc. Miscellaneous Commercial ServicesCommercial Services Certara Holdco, Inc. operates as holding company whose subsidiary provides decision support technology and consulting services for optimizing drug development and improving health outcomes. The company is headquartered in DE. | Director of Finance/CFO | 2014-07-31 |
Former positions of Michael Schemick
Companies | Position | End |
---|---|---|
CERTARA, INC. | Director of Finance/CFO | 2023-03-31 |
Haights Cross Communications, Inc.
Haights Cross Communications, Inc. Commercial Printing/FormsCommercial Services Haights Cross Communications, Inc. publishes test preparation and supplemental education materials. The company is headquartered in New York, NY. | Corporate Officer/Principal | 2014-07-31 |
░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
░░░░░ ░ ░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Training of Michael Schemick
Rutgers State University of New Jersey | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
ASBURY AUTOMOTIVE GROUP, INC. | Retail Trade |
CERTARA, INC. | Technology Services |
Private companies | 12 |
---|---|
Level 3 GC Ltd.
Level 3 GC Ltd. Specialty TelecommunicationsCommunications Level 3GC Ltd. operates as a global communications service provider. It offers data, voice and collaboration services to the companies in the Fortune 500, as well as carriers, mobile operators and Internet service providers around the world. The company offers telecommunication solutions, including broadband, voice, data, multimedia communications, readily accessible audio, video and web-conferencing. It serves Latin American businesses through its operations in Argentina, Brazil, Chile, Colombia, Ecuador, Panama, Peru, Mexico, Venezuela, the United States and the Caribbean region. The company was founded in March 1997 and is headquartered in Hamilton, Bermuda. | Communications |
Kaplan, Inc.
Kaplan, Inc. Miscellaneous Commercial ServicesCommercial Services Kaplan, Inc. provides educational and professional training services. It offers higher education, professional training, test preparation, services for K12 schools, and after school learning programs. The firm offers services in four major areas: Kaplan Kids and Schools, Kaplan Test Prep and Admissions, Kaplan Higher Education, and Kaplan Professional. The company was founded by Stanley H. Kaplan in 1938 and is headquartered in Alpharetta, GA. | Commercial Services |
Supresta LLC
Supresta LLC Chemicals: Major DiversifiedProcess Industries Supresta LLC manufactures and distributes organophosphorus flame retardants, plasticizers, additives, and lubricants. Its products include Fyrol, Phosflex, Fyrolflex, Fyrquel, Syn-O-Ad, and Victawet. The company was founded in July, 2004 and is headquartered in located in Ardsley, NY | Process Industries |
Haights Cross Communications, Inc.
Haights Cross Communications, Inc. Commercial Printing/FormsCommercial Services Haights Cross Communications, Inc. publishes test preparation and supplemental education materials. The company is headquartered in New York, NY. | Commercial Services |
Arthur Andersen LLP
Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Arthur Andersen LLP used to provide accounting services. It was also into consulting services for clients that operate businesses throughout the United States and around the world. Arthur Andersen was founded in 1913 and was headquartered in Chicago, IL. | Commercial Services |
Kaplan EduNeering, Inc.
Kaplan EduNeering, Inc. Miscellaneous Commercial ServicesCommercial Services Kaplan EduNeering, Inc. engages in the provision of online training services. The company was founded in 1980 and is headquartered in Princeton, NJ. | Commercial Services |
Certara USA, Inc.
Certara USA, Inc. Miscellaneous Commercial ServicesCommercial Services Certara USA, Inc. provides drug development consultancy solutions. It offers benefits of modeling and simulation, label optimization, pediatric drug development, orphan drug development, clinical trial outcomes databases, and therapeutic areas. The company was founded in 2008 and is headquartered in Princeton, NJ. | Commercial Services |
Certara UK Ltd.
Certara UK Ltd. BiotechnologyHealth Technology Certara UK Ltd. provides platforms for the modeling and simulation of pharmacokinetics and pharmacodynamics in virtual human populations and virtual laboratory animals. The company was founded by Geoffrey Thomas Tucker, Amin Rostami-Hodjegan, and John Evans on May 15, 2001 and is headquartered in London, the United Kingdom. | Health Technology |
XenologiQ Ltd.
XenologiQ Ltd. Miscellaneous Commercial ServicesCommercial Services XenologiQ Ltd. provides consultancy services for the drug industry. It offers services in the areas of pharmacokinetic pharmacodynamics modelling, systems pharmacology and training. The firm projects include conference presentations; dose prediction for novel biological drugs and nerve growth factor pathways systems pharmacology. The company was founded in 2011 and is headquartered in London, United Kingdom. | Commercial Services |
Certara UK Holdings Ltd.
Certara UK Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Certara, Inc., Certara UK Holdings Ltd. is a private company that develops drug therapies. The company is based in London, UK. Certara UK Holdings was founded in 2004. | Commercial Services |
LA-SER Europe Ltd.
LA-SER Europe Ltd. Pharmaceuticals: MajorHealth Technology LA-SER is a strongly science driven late-phase company with offices in 7 countries (UK, France, Germany, Spain, Italy, Canada and Morocco) encompassing a team of 150 specialists in late-phase clinical research. They cover a full range of late-phase services from observational studies, cohorts, registries, case-control studies, surveys, electronic health care database studies, pragmatic trials, they excel in risk/benefit management, effectiveness/relative effectiveness studies, and strategic consulting for drug value assessment. A truly unique feature is their in-depth understanding & knowledge of the process of drug value assessment, and of the methods, paradigms & modus operandi of regulatory decision-making bodies & agencies in several countries. Originally brought to the company by the founders of the company, this in-depth network knowledge is now shared by a large number of their senior staff. They can therefore provide remarkable insight into what evidence is required to grant market authorisation & reimbursement, for new drugs across different European countries & North America. | Health Technology |
Certara Holdco, Inc.
Certara Holdco, Inc. Miscellaneous Commercial ServicesCommercial Services Certara Holdco, Inc. operates as holding company whose subsidiary provides decision support technology and consulting services for optimizing drug development and improving health outcomes. The company is headquartered in DE. | Commercial Services |
- Stock Market
- Insiders
- Michael Schemick